Abstract
ABSTRACT BACKGROUND: The aim of this study was to compare the initial tumour volume in patients with and without pulmonary and/or skeletal metastases at time of presentation. The secondary aim was to compare the value of tumour volume in the prediction of metastases at time of presentation with known predictive factors, namely serum alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). MATERIALS AND METHODS: A retrospective cross-sectional analysis was performed comparing the primary tumour volume in patients with and without metastases. All patients with histologically confirmed high-grade conventional osteosarcoma over a five-year period were included. RESULTS: The study comprised 61 patients. The mean age was 21 years (SD: 11.9, range 5-56) with an equal distribution of males and females (51% vs 49%). There was no correlation between tumour volume and age at presentation (p=0.31). There was no evidence of metastases in only 20% (n=12) of patients. Skeletal metastases were present in 28% (n=16) of the patients and pulmonary metastases were present in 44 cases (72%). There was no significant difference in the tumour volume at presentation between patients with and without pulmonary metastases (p=0.11). However, tumour volume did appear to predict the presence of skeletal metastases (p=0.02). A tumour volume of 1 383 cm3 had a negative predictive value (NPV) of 92% and positive predictive value (PPV) of 55% for the presence of skeletal metastases (area under curve [AUC]=0.76; sensitivity 66%; specificity 87%). A tumour volume of 480 cm3 had a 100% NPV for the presence of skeletal metastases (AUC=0.74). A tumour volume > 1 380 cm3 had an odds ratio (OR) of 13.6 (p<0.01; 95% CI 2.6-72.5) as an independent variable in relation to skeletal metastases. Multivariate analysis (with ALP and LDH) of tumour volume >1 380 cm3 yielded an OR of 8.6 (p=0.04; 95% CI 1.1-67) for presence of skeletal metastases. CONCLUSION: In this series of conventional high-grade osteosarcoma of the extremities, we found a very high rate of metastases at time of diagnosis. While there was no association with pulmonary metastases, increased tumour volume was associated with an increased risk for the presence of skeletal metastases. More studies in the developing world clinical setting are required to investigate this further; the high rate of metastases seen at time of diagnosis also requires further investigation Level of evidence: Level 4. Keywords: osteosarcoma, metastases, tumour volume, prognosis, staging
Highlights
Osteosarcoma is the most common primary malignancy involving bone, excluding myeloma
One patient demised prior to completion of systemic staging investigations, and five patients were diagnosed with osteosarcoma variants
While we found no association with pulmonary metastases, we found that tumour volume was associated with the presence of skeletal metastases in our series
Summary
Osteosarcoma is the most common primary malignancy involving bone, excluding myeloma. It is rare disease, representing less than 1% of all cancers diagnosed annually in the United States of America and as a result has been classified as rare disease by the World Health Organization. The aim of this study was to compare the initial tumour volume in patients with and without pulmonary and/or skeletal metastases at time of presentation. Conclusion: In this series of conventional high-grade osteosarcoma of the extremities, we found a very high rate of metastases at time of diagnosis. More studies in the developing world clinical setting are required to investigate this further; the high rate of metastases seen at time of diagnosis requires further investigation
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
